DCO

Ducommun reported its fourth-quarter 2025 results with net revenue increasing by 9.4% over Q4 2024 and gross margin at 27.7%. Mark A. Caylor was appointed to Ducommun's Board of Directors in early May 2026, and Richard A. Baldridge sold 10,440 shares of the company's stock in March 2026. Ducommun disclosed that it must restate its 2024 and 2025 financial statements due to identified overstatements and control weaknesses related to a stock-comp error. Wall Street Zen downgraded Ducommun from "buy" to "hold" in May 2026, while other analysts maintained "buy" or "strong-buy" ratings with price target increases. Ducommun has participated in several investor conferences. As of May 7, 2026, DCO stock last traded at $137.29, and over the past 12 months, the stock has gained 116.3%.